Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Sarcoma
>>
PARP Inhibitors
>>
Phase 2
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
1
2
3
4
5
6
7
8
9
10
AiRuiYi
(fluzoparib) / Jiangsu Hengrui Pharma
Talzenna
(talazoparib) / Pfizer
Partruvix
(pamiparib) / EMD Serono, BeiGene
Rubraca
(rucaparib) / Pharma& Schweiz
iniparib
(BSI 201) / Sanofi
